Trium Capital’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Trium Capital’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,182,119	Closed	-$2.78M	–	71
2024 Q3	$2.78M	Buy	+1,182,119	New	+$2.39M	0.79%	25

Trium Capital's AUGX Position: Q4 2024 in Review

Trium Capital sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 1,182,119 shares — an estimated $2.78M sold.

Trium Capital first reported a position in AUGX in Q3 2024 and held it in 1 quarter. The position peaked at $2.78M in Q3 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Trium Capital reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Trium Capital sold 1,182,119 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $2.78M.
Trium Capital first reported a position in Augmedix, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Trium Capital's Augmedix, Inc. Common Stock position peaked at $2.78M in Q3 2024.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Trium Capital's 13F filing for Q4 2024, filed 15 Jan 2025.